A prospective cohort study of 1668 CAD patients with a follow-up of approximately 5 years demonstrate that both higher and lower serum FGF21 levels were correlated with higher risks for all-cause mortality, independent of traditional risk factors of cardiovascular diseases [18]. The gene discussed is FGF21; the disease is cardiovascular disorder.